Kalaris Therapeutics, Inc. Long-term Investment Intensity

Latest as of March 2026: 7.0%

Kalaris Therapeutics, Inc. long-term investment intensity. Kalaris Therapeutics, Inc. (KLRS) has a Long-term Investment Intensity of 7.0% as of March 2026. Long-term investments of $7.65 Million represent 7.0% of total assets of $109.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read total liabilities of Kalaris Therapeutics, Inc. for a breakdown of total debt and financial obligations.

LT Investment Intensity

7.0%
LT Investments / Total Assets

Long-term Investments

$7.65 Million
USD

Total Assets

$109.81 Million
USD

Country

USA
NASDAQ

Kalaris Therapeutics, Inc. Long-term Investment Intensity by Year (None–None)

Kalaris Therapeutics, Inc. long-term investment intensity by year from None to None. The table below presents the year-by-year Long-term Investment Intensity for Kalaris Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see KLRS asset base.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points